Chunlei Yu

Dr. Chunlei Yu

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Biochemical Pharmacology
Verified
Journal Article
Closed access
TATao An
Tao An
YGYaxiao Gong
Yaxiao Gong
XLXue Li
Xue Li
LKLingmei Kong
Lingmei Kong
PMPengcheng Ma
Pengcheng Ma
YLYan Li
Yan Li

1 April 2021 in Biochemical Pharmacology
Verified
Journal Article
Open access
XXXiaocong Xiang
Xiaocong Xiang
YTYunhong Tian
Yunhong Tian
JHJiani Hu
Jiani Hu
RXRong Xiong
Rong Xiong
MBMatthew Bautista
Matthew Bautista
GFGang Feng
Gang Feng
Autophagy has become a promising target for cancer therapy. Fangchinoline (Fan) has been shown to exert anticancer effects in some types of cancers. However, the anticancer effects on colorectal cancer (CRC) and the underlying mechanisms have never been elucidated. More specifically, regulation of autophagy in CRC by Fan has never been reported before. In the present study, Fan was found to induce apoptosis and autophagic flux in the CRC cell lines HT29 and HCT116, which was reflected by the enhanced levels of LC3-II protein and p62 degradation, and the increased formation of autophagosomes and puncta formation by LC3-II. Meanwhile, combination with the early-stage autophagy inhibitor 3-methyladenine (3-MA) but not the late-stage autophagy inhibitor chloroquine (CQ) further increased Fan-induced cell death, which suggested the cytoprotective function of autophagy induced by Fan in both HT29 and HCT116 cells. Moreover, Fan treatment demonstrated a dose- and time-dependently increase in the phosphorylation of AMPK and decrease in the phosphorylation of mammalian target of rapamycin (mTOR) and ULK1, leading to the activation of the AMPK/mTOR/ULK1 signaling pathway. Furthermore, in the HT29 xenograft model, Fan inhibited tumor growth in vivo. These results indicate that Fan inhibited CRC cell growth both in vitro and in vivo and revealed a new molecular mechanism involved in the anticancer effect of Fan on CRC, suggesting that Fan is a potent autophagy inducer and might be a promising anticancer agent.

11 January 2019 in Oncogene
Verified
Journal Article
Open access
PDF file
HZHongyu Zhou
Hongyu Zhou
CYChunlei Yu
Chunlei Yu
LKLingmei Kong
Lingmei Kong
XXXiaoliang Xu
Xiaoliang Xu
JYJuming Yan
Juming Yan
YLYan Li
Yan Li
Cancer stem cells (CSCs) have been implicated in metastasis, relapse, and therapeutic resistance of cancer, so successful cancer therapy may therefore require the development of drugs against CSCs or combining anti-CSCs drugs with conventional therapies. The phosphoinositide 3-kinase (PI3K) signaling pathway is one of the most frequently activated signaling pathways in human cancer, playing a central role in tumorigenesis as well as the maintenance of CSCs. Here, we designed and identified B591, a dihydrobenzofuran-imidazolium salt, as a novel specific pan-PI3K inhibitor with potent inhibitory activity against class I PI3K isoforms, which showed effective inhibition of cellular PI3K/mTOR signaling pathway and robust antitumor activity in a set of cancer cell lines. Notably, compared with bulk tumor cell populations, B591 exhibited more potency in suppressing CSCs survival and inducing CSCs apoptosis, and presence of B591 effectively eliminated paclitaxel-enriched CSCs. B591 diminished self-renewal capacity and decreased the expression of epithelial-mesenchymal transition (EMT) markers of CSCs. In vivo, B591 preferentially decreased CSCs levels in mouse xenograft model of human breast cancer as evidenced especially by remarkable reduction of tumor-initiating ability. Consistent with the preferential targeting of CSCs, B591 effectively inhibited breast tumor metastasis and delayed tumor regrowth following paclitaxel treatment. Taken together, our findings establish B591, a novel PI3K inhibitor, as a strong candidate for clinical evaluation as a CSCs targeting agent.

7 July 2016 in Biochemical Pharmacology
Verified
Journal Article
Closed access
HZHongyu Zhou
Hongyu Zhou
CSChaowei Shang
Chaowei Shang
MWMin Wang
Min Wang
TSTao Shen
Tao Shen
LKLingmei Kong
Lingmei Kong
Shile HuangShile Huang
Shile Huang

29 September 2016 in Apoptosis
Verified
Journal Article
Closed access
PDF file
HLHan Liu
Han Liu
CYChunlei Yu
Chunlei Yu
TXTianjiao Xu
Tianjiao Xu
XZXiaojie Zhang
Xiaojie Zhang
MDMiaoxian Dong
Miaoxian Dong

24 November 2014 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
XXXiao-Liang Xu
Xiao-Liang Xu
CYChunlei Yu
Chunlei Yu
WCWen Chen
Wen Chen
YLYing-Chao Li
Ying-Chao Li
LYLi-Juan Yang
Li-Juan Yang
XYXiao-Dong Yang
Xiao-Dong Yang
A series of novel 2-substituted indoline imidazolium salt derivatives has been prepared and evaluated in vitro against a panel of human tumor cell lines. The results suggest that the existence of a substituted benzimidazole ring and substitution of the imidazolyl-3-position with a naphthylacyl or 2-naphthylmethyl group were vital for modulating the cytotoxic activity. Compound 25 was found to be the most potent derivative with IC50 values of 0.24–1.18 μM, and exhibited cytotoxic activity selectively against MCF-7, SW480, SMMC-7721 and HL-60 cell lines, while compound 26 showed powerful inhibitory activities selectively against SMMC-7721 and A549 cell lines. Compound 25 can induce G2/M phase cell cycle arrest and apoptosis in SMMC-7721 cells.